Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Fixed Capital/Sales

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Fixed Capital/Sales(x) 0.440.420.360.29

What is the latest Fixed Capital/Sales ratio of CORONA REMEDIES ?

The latest Fixed Capital/Sales ratio of CORONA REMEDIES is 0.44 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.44
Mar20250.42
Mar20240.36
Mar20230.29

How is Fixed Capital/Sales of CORONA REMEDIES Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.44
4.76
Mar2025 0.42
16.67
Mar2024 0.36
24.14
Mar2023 0.29 -

Other Financial Ratios of CORONA REMEDIES


Compare Fixed Capital/Sales ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,945.9 Cr -4.5% 0.4% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-4.5%

0.4%

NA
SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses